{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:12:52Z","timestamp":1774566772524,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1016\/s0006-8993(97)01204-3","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:02:28Z","timestamp":1027634548000},"page":"210-218","source":"Crossref","is-referenced-by-count":56,"title":["NSAIDS inhibit the IL-1\u03b2-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2"],"prefix":"10.1016","volume":"777","author":[{"given":"Michaela A.A","family":"Blom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margriete G.H","family":"van Twillert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine C","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Engels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb E","family":"Finch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Veerhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Eikelenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0006-8993(97)01204-3_BIB1","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.45.8.1441","article-title":"Do non-steroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam study","volume":"45","author":"Anderson","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.44.2.227","article-title":"Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a control co-twin study","volume":"44","author":"Breitner","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/rheumatology\/28.1.86-b","article-title":"Rheumatoid arthritis and senile dementia of Alzheimer's type","volume":"28","author":"Jenkinson","year":"1989","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","article-title":"Clinical trial of indomethacin in Alzheimer's disease","volume":"43","author":"Rogers","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.48.3.626","article-title":"Risk of Alzheimer's disease and duration of NSAID use","volume":"48","author":"Stewart","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(88)90462-X","article-title":"Immunochemical identification of the serine protease inhibitor \u03b11-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease","volume":"52","author":"Abraham","year":"1988","journal-title":"Cell"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-5793(91)80737-N","article-title":"Interleukin-6 and \u03b12-macroglobulin indicate an acute phase state in Alzheimer's disease cortices","volume":"285","author":"Bauer","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00685397","article-title":"Immunoglobulins and complement factors in senile plaques","volume":"57","author":"Eikelenboom","year":"1982","journal-title":"Acta Neuropathol. (Berl)"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0923-2494(92)80044-L","article-title":"Distribution pattern and functional state of complement proteins and \u03b11-antichymotrypsin in cerebral \u03b2\/A4 deposits in Alzheimer's disease","volume":"143","author":"Eikelenboom","year":"1992","journal-title":"Res. Immunol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005072-199503000-00014","article-title":"Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution","volume":"54","author":"Griffin","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/BF00571510","article-title":"Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients","volume":"89","author":"Huell","year":"1995","journal-title":"Acta Neuropathol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0923-2494(92)80050-U","article-title":"Activated microglia and cerebral amyloid deposits in Alzheimer's disease","volume":"143","author":"Rozemuller","year":"1992","journal-title":"Res. Immunol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jnr.490400407","article-title":"Complement and cytokine gene expression in cultured microglia derived from post-mortem human brains","volume":"40","author":"Walker","year":"1995","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB14","first-page":"1","article-title":"Mechanisms of inflammation in Alzheimer's disease","volume":"6","author":"Blom","year":"1996","journal-title":"An. Psychiatry"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB15","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1073\/pnas.89.21.10075","article-title":"Cholinergic agonists and interleukin-1 regulate processing and secretion of the \u03b2\/A4 amyloid protein precursor","volume":"89","author":"Buxbaum","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0304-3940(95)11384-9","article-title":"Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and \u03b2-amyloid production in cultures","volume":"188","author":"Del Bo","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0165-6147(94)90057-4","article-title":"Inflammatory mechanisms in Alzheimer's disease","volume":"15","author":"Eikelenboom","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB18","doi-asserted-by":"crossref","first-page":"10738","DOI":"10.1073\/pnas.92.23.10738","article-title":"Amyloid \u03b2 peptide potentiates cytokine secretion by interleukin-1\u03b2-activated human astrocytoma cells","volume":"92","author":"Gitter","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB19","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1073\/pnas.86.19.7606","article-title":"Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells","volume":"86","author":"Goldgaber","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB20","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1523\/JNEUROSCI.08-07-02485.1988","article-title":"Interleukin-1 injected in mammalian brain stimulates astrogliosis and neurovascularization","volume":"8","author":"Guilian","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0167-5699(91)90032-O","article-title":"Is amyloidogenesis during Alzheimer's disease due to an IL-1\/IL-6-mediated `acute phase response' in the brain?","volume":"12","author":"Vandenabeele","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB22","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1046\/j.1471-4159.1996.66062468.x","article-title":"Amyloid \u03b2 protein (A\u03b2) primes cultured rat microglial cells for an enhanced phorbol-myristate-acetate induced respiratory burst activity","volume":"66","author":"Van Muiswinkel","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/ajp.151.8.1105","article-title":"Inflammatory mechanisms in Alzheimer's disease: implications for therapy","volume":"151","author":"Aisen","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB24","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/0197-4580(94)90199-6","article-title":"New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause","volume":"150","author":"Breitner","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.47.1.401","article-title":"The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease","volume":"47","author":"Breitner","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0197-4580(96)00107-8","article-title":"Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options","volume":"17","author":"H\u00fcll","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB27","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0140-6736(90)91101-F","article-title":"Anti-inflammatory drugs and Alzheimer's disease","volume":"335","author":"McGeer","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer's disease and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res. Rev."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-199609010-00001","article-title":"Do non-steroidal anti-inflammatory drugs (NSAID's) have a protective effect against dementia?","volume":"9","author":"Van Muiswinkel","year":"1996","journal-title":"Drugs and Aging"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB30","first-page":"542","article-title":"Enhanced processing of APP induced by IL-1\u03b2 can be reduced by indomethacin and nordihydroguaiaretic acid","volume":"208","author":"Dash","year":"1995","journal-title":"B.B.R.C."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0006-8993(96)00259-4","article-title":"IL-1 and anti-inflammatory drugs modulate A\u03b2 cytotoxicity in PC12 cells","volume":"723","author":"Fagarasan","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-5793(89)81210-4","article-title":"Dexamethasone regulation of the expression of cytokine mRNAs induced by interleukin-1 in the astrocytoma cell line U373MG","volume":"243","author":"Nishida","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB33","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1073\/pnas.90.21.10061","article-title":"Neurologic disease induced in transgenic mice cerebral overexpression of interleukin 6","volume":"90","author":"Campbell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB34","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.149.7.2358","article-title":"Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1\u03b2 and tumor necrosis factor-\u03b1","volume":"149","author":"Aloisi","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005072-199703000-00007","article-title":"Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1\u03b1+ and S\u03b2+ astrocytes with neurofibrillary tangle stages","volume":"56","author":"Sheng","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB36","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1046\/j.1365-2036.1996.22164025.x","article-title":"Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies","volume":"10","author":"Brattsand","year":"1996","journal-title":"Alim. Pharm. Therap."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB37","unstructured":"Haynes, R.C. Jr., ACTH; adrenocortical steroids; inhibitors of synthesis, in: A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn., New York, Pergamon Press, 1990."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-6147(96)01017-6","article-title":"A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes","volume":"8","author":"Fr\u00f6lich","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-5728(96)00111-7","article-title":"Recombinant human interleukin 1\u03b2 induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures","volume":"71","author":"Dayton","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB40","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1471-4159.1997.68020704.x","article-title":"Prostaglandin E2 induces interleukin-6 synthesis in human astroglioma cells","volume":"68","author":"Fiebich","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB41","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.90.24.11693","article-title":"Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase","volume":"90","author":"Mitchell","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB42","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1046\/j.1471-4159.1996.66062532.x","article-title":"Interleukin-1\u03b2 induces prostaglandin G\/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures","volume":"66","author":"O'Banion","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB43","first-page":"41","article-title":"Mediation of inflammation by cyclooxygenase-2","volume":"46","author":"Siebert","year":"1995","journal-title":"Agents and actions"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB44","first-page":"300","article-title":"Anti-inflammatory activity of BF389, a di-T-butylphenol, in animal models of arthritis","volume":"260","author":"Bendele","year":"1992","journal-title":"J. Pharmac. Exp. Therap."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1097-4547(19970801)49:3<342::AID-JNR9>3.0.CO;2-C","article-title":"Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization","volume":"49","author":"De Groot","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anti-cancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001721-199102000-00002","article-title":"Production of thromboxane and prostaglandins in human blood in the of thromboxane synthase inhibitors: a comparison of RIA and GC\/MS determinations","volume":"2","author":"Weber","year":"1991","journal-title":"Blood Coagulat. Fibrinol."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1600-051X.1996.tb00587.x","article-title":"Prostaglandin E2 potentiates interleukin-1\u03b2 induced IL-6 production by human gingival fibroblasts","volume":"7","author":"Czuszak","year":"1996","journal-title":"J. Clin. Periodon."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB49","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1073\/pnas.93.10.4885","article-title":"Elevated interleukin-6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cycloogenase-2","volume":"14","author":"Hinson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB50","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.91.8.3228","article-title":"Selective inhibition of inducable cyclooxygenase 2 in vivo is antiinflammatory and non ulcerogenic","volume":"91","author":"Masferrer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB51","first-page":"232","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0006-8993(97)00067-X","article-title":"Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations","volume":"754","author":"Williams","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0197-4580(96)00110-8","article-title":"Prostaglandin G\/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease","volume":"17","author":"Chang","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0197-0186(92)90147-J","article-title":"Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease","volume":"21","author":"Wong","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.270.5234.283","article-title":"Role of transcriptional activation of I kappa B alpha in mediation immunosuppression by glucocorticoids","volume":"270","author":"Scheinman","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0006-8993(97)01204-3_BIB56","first-page":"231","article-title":"Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kB-like nuclear protein","volume":"39","author":"Sparacio","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB57","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue","volume":"266","author":"Kujubu","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0006-8993(97)01204-3_BIB58","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1073\/pnas.91.2.752","article-title":"Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor","volume":"91","author":"Ray","year":"1994","journal-title":"Proc. Nat. Acad. Sci. U.S.A."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899397012043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899397012043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T02:17:29Z","timestamp":1681438649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899397012043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":58,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["S0006899397012043"],"URL":"https:\/\/doi.org\/10.1016\/s0006-8993(97)01204-3","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}